Medicskin Holdings Management

Management Kriterienprüfungen 2/4

Medicskin Holdings' CEO ist Kwok Leung Kong, ernannt in Mar 2018, hat eine Amtszeit von 6.17 Jahren. Die jährliche Gesamtvergütung beträgt HK$6.20M, bestehend aus 68.1% Gehalt und 31.9% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 69.28% der Aktien des Unternehmens, im Wert von HK$38.48M. Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 10.2 Jahre bzw. 9.4 Jahre.

Wichtige Informationen

Kwok Leung Kong

Geschäftsführender

HK$7.1m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts	59.3%
Amtszeit als Geschäftsführer	6.3yrs
Eigentum des Geschäftsführers	69.3%
Durchschnittliche Amtszeit des Managements	10.3yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder	9.6yrs

Jüngste Management Updates

We Think Some Shareholders May Hesitate To Increase Medicskin Holdings Limited's (HKG:8307) CEO Compensation

Sep 15

Recent updates

We Think Some Shareholders May Hesitate To Increase Medicskin Holdings Limited's (HKG:8307) CEO Compensation

Sep 15

Here's Why Shareholders May Want To Be Cautious With Increasing Medicskin Holdings Limited's (HKG:8307) CEO Pay Packet

Sep 16

Here's Why We Think Medicskin Holdings (HKG:8307) Is Well Worth Watching

Jul 18

Investor Optimism Abounds Medicskin Holdings Limited (HKG:8307) But Growth Is Lacking

Jun 11

A Look At The Fair Value Of Medicskin Holdings Limited (HKG:8307)

Feb 25

Shareholders Will Probably Hold Off On Increasing Medicskin Holdings Limited's (HKG:8307) CEO Compensation For The Time Being

Sep 15

Can Mixed Fundamentals Have A Negative Impact on Medicskin Holdings Limited (HKG:8307) Current Share Price Momentum?

Feb 11

Our Take On Medicskin Holdings' (HKG:8307) CEO Salary

Dec 16

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Kwok Leung Kong im Vergleich zu den Einnahmen von Medicskin Holdings verändert?
Datum	Gesamtvergütung	Gehalt	Unternehmensgewinne
Mar 31 2024	HK$7m	n/a	-HK$3m
Dec 31 2023	n/a	n/a	-HK$3m
Sep 30 2023	n/a	n/a	-HK$2m
Jun 30 2023	n/a	n/a	-HK$3m
Mar 31 2023	HK$6m	HK$4m	-HK$4m
Dec 31 2022	n/a	n/a	-HK$2m
Sep 30 2022	n/a	n/a	-HK$1m
Jun 30 2022	n/a	n/a	HK$2m
Mar 31 2022	HK$6m	HK$5m	HK$4m
Dec 31 2021	n/a	n/a	HK$908k
Sep 30 2021	n/a	n/a	HK$872k
Jun 30 2021	n/a	n/a	HK$2m
Mar 31 2021	HK$5m	HK$4m	HK$953k
Dec 31 2020	n/a	n/a	HK$931k
Sep 30 2020	n/a	n/a	-HK$750k
Jun 30 2020	n/a	n/a	-HK$2m
Mar 31 2020	HK$6m	HK$3m	-HK$3m
Dec 31 2019	n/a	n/a	-HK$3m
Sep 30 2019	n/a	n/a	-HK$3m
Jun 30 2019	n/a	n/a	-HK$5m
Mar 31 2019	HK$7m	HK$3m	-HK$5m
Dec 31 2018	n/a	n/a	-HK$2m
Sep 30 2018	n/a	n/a	-HK$1m
Jun 30 2018	n/a	n/a	HK$722k
Mar 31 2018	HK$7m	HK$3m	HK$3m

Vergütung im Vergleich zum Markt: Kwok LeungDie Gesamtvergütung ($USD792.91K) liegt über dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt Hong Kong ($USD231.79K).

Entschädigung vs. Einkommen: Kwok LeungDie Bezüge der Mitarbeiter sind gestiegen, während das Unternehmen unrentabel ist.

Geschäftsführer

Kwok Leung Kong (70 yo)

6.3yrs

Amtszeit

HK$7,104,000

Vergütung

Dr. Kwok Leung Kong serves as Chief Executive officer of Medicskin Holdings Ltd (“Company”) since March 01, 2018 and serves as its Founder and Chairman of the Board. Dr. Kong graduated from the Faculty of...

Führungsteam

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Kwok Leung Kong	Founder	6.3yrs	HK$7.10m	69.28% HK$ 55.0m
Chui Pik Sin	CFO, Company Secretary & Executive Director	10.3yrs	HK$1.10m	keine Daten
Chung Wai Kong	Legal & Compliance Officer and Executive Director	no data	HK$455.00k	keine Daten
Sze Suet Ling	Head of Business & Product Development and Medicskin Centre Manager	11.5yrs	keine Daten	keine Daten
Kan Tsui	VP & Executive Director	no data	HK$622.00k	keine Daten

10.3yrs

Durchschnittliche Betriebszugehörigkeit

45yo

Durchschnittliches Alter

Erfahrenes Management: Das Managementteam von 8307 ist erfahren und erfahren (durchschnittliche Amtszeit: 10.2 Jahre).

Vorstandsmitglieder

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Kwok Leung Kong	Founder	10.1yrs	HK$7.10m	69.28% HK$ 55.0m
Chui Pik Sin	CFO, Company Secretary & Executive Director	7.5yrs	HK$1.10m	keine Daten
Chung Wai Kong	Legal & Compliance Officer and Executive Director	10yrs	HK$455.00k	keine Daten
Kan Tsui	VP & Executive Director	6.3yrs	HK$622.00k	keine Daten
Siu Cheung Leung	Independent Non-Executive Director	9.6yrs	HK$180.00k	keine Daten
Cheong Tat Chan	Independent Non-Executive Director	9.6yrs	HK$180.00k	keine Daten
Sze On Lui	Independent Non-Executive Director	less than a year	HK$103.00k	keine Daten

9.6yrs

Durchschnittliche Betriebszugehörigkeit

51yo

Durchschnittliches Alter

Erfahrener Vorstand: 8307Die Vorstandsmitglieder gelten als erfahren (9.4 Jahre durchschnittliche Amtszeit).

Medicskin Holdings Management

Management Kriterienprüfungen 2/4

Wichtige Informationen

Jüngste Management Updates

Medicskin Holdings Limited, Annual General Meeting, Sep 06, 2024

We Think Some Shareholders May Hesitate To Increase Medicskin Holdings Limited's (HKG:8307) CEO Compensation

Medicskin Holdings Limited Announces Appointment of Lui Sze On as Independent Non-Executive Director and Member of the Audit Committee, Remuneration Committee and Nomination Committee of the Board with Effect from September 6, 2023

Medicskin Holdings Limited, Annual General Meeting, Sep 01, 2023

Medicskin Holdings Limited Announces Resignation of Fu Frank Tsun Yin as Independent Non-Executive Director and A Member of the Audit Committee, Remuneration Committee and Nomination Committee

Medicskin Holdings Limited Appoints Fu Frank Tsun Yin as an Independent Non-Executive Director and A Member of Each of the Audit Committee, Remuneration Committee and Nomination Committee of the Board with Effect from 14 February 2023

Recent updates

Medicskin Holdings Limited, Annual General Meeting, Sep 06, 2024

Full year 2024 earnings released: HK$0.008 loss per share (vs HK$0.008 loss in FY 2023)

Now 34% overvalued after recent price rise

New minor risk - Financial data availability

Medicskin Holdings Limited to Report Fiscal Year 2024 Results on Jun 19, 2024

New minor risk - Share price stability

Now 20% overvalued after recent price rise

Now 23% undervalued after recent price drop

Second quarter 2024 earnings released: HK$0.004 loss per share (vs HK$0.006 loss in 2Q 2023)

New major risk - Market cap size

Medicskin Holdings Limited to Report Q2, 2024 Results on Nov 13, 2023

We Think Some Shareholders May Hesitate To Increase Medicskin Holdings Limited's (HKG:8307) CEO Compensation

Medicskin Holdings Limited Announces Appointment of Lui Sze On as Independent Non-Executive Director and Member of the Audit Committee, Remuneration Committee and Nomination Committee of the Board with Effect from September 6, 2023

New minor risk - Financial position

First quarter 2024 earnings released: HK$0.001 loss per share (vs HK$0.002 loss in 1Q 2023)

First quarter 2024 earnings released: HK$0.001 loss per share (vs HK$0.002 loss in 1Q 2023)

Medicskin Holdings Limited to Report Q1, 2024 Results on Aug 14, 2023

Medicskin Holdings Limited, Annual General Meeting, Sep 01, 2023

New minor risk - Share price stability

Full year 2023 earnings released: HK$0.007 loss per share (vs HK$0.01 profit in FY 2022)

Medicskin Holdings Limited Announces Resignation of Fu Frank Tsun Yin as Independent Non-Executive Director and A Member of the Audit Committee, Remuneration Committee and Nomination Committee

Medicskin Holdings Limited to Report Fiscal Year 2023 Results on Jun 21, 2023

Medicskin Holdings Limited Appoints Fu Frank Tsun Yin as an Independent Non-Executive Director and A Member of Each of the Audit Committee, Remuneration Committee and Nomination Committee of the Board with Effect from 14 February 2023

Third quarter 2023 earnings released: EPS: HK$0 (vs HK$0.004 in 3Q 2022)

Medicskin Holdings Limited to Report Q3, 2023 Results on Feb 13, 2023

Second quarter 2023 earnings released: HK$0.006 loss per share (vs HK$0.001 profit in 2Q 2022)

Medicskin Holdings Limited Announces Resignation of Lee Ka Lun as Independent Non-Executive Director and Member of the Audit Committee, Remuneration Committee and Nomination Committee

Less than half of directors are independent

Medicskin Holdings Limited Provides Unaudited Consolidated Earnings Guidance for Six Months Ended 30 September 2022

Medicskin Holdings Limited to Report First Half, 2023 Results on Nov 14, 2022

Here's Why Shareholders May Want To Be Cautious With Increasing Medicskin Holdings Limited's (HKG:8307) CEO Pay Packet

First quarter 2023 earnings released: HK$0.002 loss per share (vs HK$0.004 profit in 1Q 2022)

Medicskin Holdings Limited Provides Consolidated Earnings Guidance for the Three Months Ended June 30, 2022

Here's Why We Think Medicskin Holdings (HKG:8307) Is Well Worth Watching

Medicskin Holdings Limited, Annual General Meeting, Sep 23, 2022

Full year 2022 earnings released

Medicskin Holdings Limited, Annual General Meeting, Sep 23, 2022

Investor Optimism Abounds Medicskin Holdings Limited (HKG:8307) But Growth Is Lacking

Medicskin Holdings Limited to Report Fiscal Year 2022 Results on Jun 20, 2022

Less than half of directors are independent

Now 20% undervalued

A Look At The Fair Value Of Medicskin Holdings Limited (HKG:8307)

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Second quarter 2022 earnings released: EPS HK$0.001 (vs HK$0.002 in 2Q 2021)

Shareholders Will Probably Hold Off On Increasing Medicskin Holdings Limited's (HKG:8307) CEO Compensation For The Time Being

First quarter 2022 earnings released: EPS HK$0.004 (vs HK$0.002 in 1Q 2021)

Inaugural dividend of HK$0.025 per share

Full year 2021 earnings released: EPS HK$0.002 (vs HK$0.007 loss in FY 2020)

Medicskin Holdings Limited Announces Special Dividend for the Year Ended 31 March 2021, Payable on or around 26 July 2021

New 90-day high: HK$0.29

Can Mixed Fundamentals Have A Negative Impact on Medicskin Holdings Limited (HKG:8307) Current Share Price Momentum?

Third quarter 2021 earnings released: EPS HK$0.004 (vs HK$0.001 loss in 3Q 2020)

New 90-day high: HK$0.28

Medicskin Holdings Limited to Report Nine Months, 2021 Results on Feb 10, 2021

New 90-day high: HK$0.22

Our Take On Medicskin Holdings' (HKG:8307) CEO Salary

New 90-day high: HK$0.21

Second quarter 2021 earnings released: EPS HK$0.002

Medicskin Holdings Limited to Report First Half, 2021 Results on Nov 13, 2020

First quarter earnings released

Medicskin Holdings Limited to Report Q1, 2021 Results on Aug 14, 2020

Analyse der Geschäftsführervergütung

Geschäftsführer

Amtszeit

Vergütung

Führungsteam

Durchschnittliche Betriebszugehörigkeit

Durchschnittliches Alter

Vorstandsmitglieder